The eIF2 kinase GCN2 is essential for the murine immune system to adapt to amino acid deprivation by asparaginase.
Amino acid starvation by asparaginase (ASNase) enhances phosphorylation of eukaryotic initiation factor 2 (eIF2) by general control nonderepressible 2 (GCN2) kinase, leading to reduced global mRNA translation rates. This conserves energy and allows cells time to reprogram stress-related gene expression to alleviate cell injury. This study addressed the importance of GCN2 for the immune system to adapt to amino acid starvation by ASNase. GCN2(+/+) and GCN2(-/-) mice were injected once daily with ASNase or saline for up to 7 d. In both thymus and spleen, activation of amino acid stress response genes to ASNase, such as asparagine synthetase and CAAT enhancer binding protein homologous protein, required GCN2. ASNase reduced food intake and body weight in both genotypes, but spleen and thymus wet weights and total cell numbers in thymus, spleen, bone marrow, and mesenteric lymph nodes were less in GCN2(-/-) mice treated with ASNase (genotype x ASNase, P < 0.05). In the thymus, GCN2(-/-) mice treated with ASNase demonstrated enhanced apoptosis and fewer cells in all subpopulations examined (CD3+, CD4-8-, CD4+8+, CD4+8-, CD4-8+) compared with GCN2(+/+) mice treated with ASNase (genotype x ASNase, P < 0.05). In the spleen, GCN2 deletion magnified ASNase-induced reductions in CD4+ T cells, CD8+ T cells, CD19+ B cells, and CD11b+ leukocytes (genotype x ASNase, P < 0.05). These results indicate that loss of GCN2 enhances immunosuppression by ASNase and that this eIF2 kinase is broadly required for amino acid stress management in the immune system.
Bunpo
Piyawan
P
Department of Biochemistry and Molecular Biology, Indiana University School of Medicine-Evansville, Evansville, IN 47712, USA.
Cundiff
Judy K
JK
Reinert
Rachel B
RB
Wek
Ronald C
RC
Aldrich
Carla J
CJ
Anthony
Tracy G
TG
D000596:Amino Acids / Q000172:deficiency*; D000818:Animals; D000970:Antineoplastic Agents / Q000633:toxicity*; D017209:Apoptosis / Q000187:drug effects; D001215:Asparaginase / Q000378:metabolism / Q000633:toxicity*; D001217:Aspartate-Ammonia Ligase / Q000235:genetics / Q000378:metabolism; D001854:Bone Marrow Cells / Q000187:drug effects; D002452:Cell Count; D005260:Female; D007107:Immune System / Q000187:drug effects* / Q000502:physiology*; D007166:Immunosuppressive Agents / Q000633:toxicity; D016131:Lymphocyte Subsets / Q000187:drug effects / Q000378:metabolism; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D009929:Organ Size / Q000187:drug effects; D017346:Protein Serine-Threonine Kinases / Q000235:genetics / Q000502:physiology*; D012333:RNA, Messenger / Q000378:metabolism; D013154:Spleen / Q000187:drug effects; D013312:Stress, Physiological / Q000235:genetics*; D013950:Thymus Gland / Q000187:drug effects; D051742:Transcription Factor CHOP / Q000235:genetics / Q000378:metabolism
D000596:Amino Acids; D000970:Antineoplastic Agents; C497250:Ddit3 protein, mouse; D007166:Immunosuppressive Agents; D012333:RNA, Messenger; D051742:Transcription Factor CHOP; C070634:Eif2ak4 protein, mouse; D017346:Protein Serine-Threonine Kinases; D001215:Asparaginase; D001217:Aspartate-Ammonia Ligase